Search Orphan Drug Designations and Approvals
-
Generic Name: | TransCon Parathyroid Hormone (mPEG conjugated parathyroid hormone 1-34) |
---|---|
Date Designated: | 06/04/2018 |
Orphan Designation: | Treatment of hypoparathyroidism |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Ascendis Pharma Bone Diseases A/S Tuborg Boulevard 5 DK-2900 Hellerup Denmark The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-